Biocryst Pharmaceuticals, Inc. · NASDAQ:BCRX
Ra Capital Management, L.P. reported a 6.20% stake in Biocryst Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ra Capital Management, L.P. reported a 6.20% stake in Biocryst Pharmaceuticals, Inc., 15,827,186 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 15,827,186
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 6.20% | 15,827,186 |
| Peter Kolchinsky | 6.20% | 15,827,186 |
| Rajeev Shah | 6.20% | 15,827,186 |
| RA Capital Healthcare Fund, L.P. | 6.20% | 15,827,186 |
Source
Related
- Biocryst Pharmaceuticals, Inc.
- Ra Capital Management, L.P.
- Biocryst Pharmaceuticals, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Nov 12, 2025
- Form 4 · Stonehouse Jon P · Sep 2, 2026
- Form 4 · Milne Jill C. · Sep 2, 2026
- Form 4 · Milano Vincent · Sep 2, 2026
- Form 4 · McKee Amy E · Sep 2, 2026
- Form 4 · Frank Steven · Sep 2, 2026